600998 Stock Overview
Jointown Pharmaceutical Group Co., Ltd provides pharmaceutical supply chain services in China.
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 1/6 |
Past Performance | 5/6 |
Financial Health | 6/6 |
Dividends | 5/6 |
Jointown Pharmaceutical Group Co., Ltd Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥7.75 |
52 Week High | CN¥8.95 |
52 Week Low | CN¥6.50 |
Beta | 0.13 |
1 Month Change | -0.77% |
3 Month Change | 10.24% |
1 Year Change | 5.94% |
3 Year Change | -10.43% |
5 Year Change | 1.93% |
Change since IPO | -14.82% |
Recent News & Updates
Recent updates
Shareholder Returns
600998 | CN Healthcare | CN Market | |
---|---|---|---|
7D | -3.7% | -4.4% | -2.2% |
1Y | 5.9% | -31.8% | -14.8% |
Return vs Industry: 600998 exceeded the CN Healthcare industry which returned -31.8% over the past year.
Return vs Market: 600998 exceeded the CN Market which returned -14.8% over the past year.
Price Volatility
600998 volatility | |
---|---|
600998 Average Weekly Movement | 4.8% |
Healthcare Industry Average Movement | 6.6% |
Market Average Movement | 8.1% |
10% most volatile stocks in CN Market | 11.4% |
10% least volatile stocks in CN Market | 5.1% |
Stable Share Price: 600998 has not had significant price volatility in the past 3 months.
Volatility Over Time: 600998's weekly volatility (5%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1999 | 30,141 | Wei He | https://www.jztey.com |
Jointown Pharmaceutical Group Co., Ltd provides pharmaceutical supply chain services in China. It is also involved in general agency brand promotion; digital retail; intelligent logistics and supply chain solutions; and medical health and technology value-added service businesses. In addition, the company manufactures western medicines, such as antibiotics, anti-diabetic drugs, and cardiovascular drugs; and other OEM medicines.
Jointown Pharmaceutical Group Co., Ltd Fundamentals Summary
600998 fundamental statistics | |
---|---|
Market cap | CN¥29.51b |
Earnings (TTM) | CN¥2.17b |
Revenue (TTM) | CN¥151.84b |
13.6x
P/E Ratio0.2x
P/S RatioIs 600998 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
600998 income statement (TTM) | |
---|---|
Revenue | CN¥151.84b |
Cost of Revenue | CN¥139.72b |
Gross Profit | CN¥12.12b |
Other Expenses | CN¥9.95b |
Earnings | CN¥2.17b |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
Apr 27, 2024
Earnings per share (EPS) | 0.57 |
Gross Margin | 7.98% |
Net Profit Margin | 1.43% |
Debt/Equity Ratio | 57.2% |
How did 600998 perform over the long term?
See historical performance and comparison